Inevitable Cancer Development Linked to Pfizer and Moderna COVID Vaccines Can Be Combated with Ivermectin
In recent times, there has been a growing debate surrounding the use of ivermectin, an antiparasitic drug, as a potential cancer treatment. While preclinical studies have shown some promising anticancer effects, it is crucial to distinguish between these laboratory findings and the real-world application in humans.
Ivermectin has demonstrated the ability to inhibit tumor growth in a breast cancer mouse model at a human dose of two mg/kg. However, it is essential to note that these findings are primarily from preclinical studies and not from robust, large-scale clinical trials in humans. The clinical use of ivermectin for cancer remains experimental, with no approved guidelines and a lack of Phase 1/2/3 trials.
Contrary to some claims, there is currently no credible scientific evidence supporting the use of ivermectin as a cancer treatment specifically for chemotherapy-resistant tumors caused by COVID-19 mRNA vaccines. The premise that chemotherapy-resistant tumors are caused by COVID-19 mRNA vaccines has no scientific support in current medical literature or authorized clinical research.
The U.S. Food and Drug Administration (FDA) has taken a stance on this matter, agreeing to permanently take down its social media posts urging people to avoid using ivermectin for COVID-19. A lawsuit was filed against the FDA by doctors Paul Marik, Mary Talley Bowden, and Robert Apter, alleging that the FDA is meddling with their capacity to practice medicine. However, the lawsuit was initially dismissed based on the FDA's "sovereign immunity."
It is important to emphasize that ivermectin, while showing potential in certain cancer cell lines, is not a substitute for evidence-based cancer treatments like chemotherapy. Healthcare experts caution against using ivermectin as a cancer therapy outside of approved clinical trials and warn against misinformation that may lead patients to forgo proven treatments.
In terms of the drug's sensitivity across various cancer cell lines, the most sensitive are ovarian, breast, glioblastoma (brain), lung, colon, uterine squamous cell carcinoma (SCC), hepatocellular, triple-negative breast cancer (TNBC), pancreatic, and endometrial. On the other hand, osteosarcoma, gastric, and melanoma cell lines are the least sensitive to ivermectin.
The debate surrounding ivermectin's use in cancer treatment is complex and ongoing. As more research is conducted, it is hoped that a clearer understanding of the drug's potential role in cancer therapy will emerge. However, it is crucial that any decisions regarding treatment are made in consultation with healthcare providers and based on the best available evidence.
References: 1. Natural News 2. Makismd.substack.com 3. HindustanTimes.com 4. Robert F. Kennedy Jr tweet 5. Dr. Mary Talley Bowden's Twitter comment 6. U.S. Court of Appeals for the Fifth Circuit ruling 7. Australian politician Craig Kelly's statement 8. FDA's removal of posts
- The growing debate about ivermectin's potential role in cancer treatment is extensively covered in various articles, including those on Natural News and Makismd.substack.com.
- The truth about ivermectin's effectiveness as a cancer treatment is a topic of debate, with some advocating for its use in preclinical studies, but its real-world application remains uncertain.
- Despite claims suggesting ivermectin can treat chemotherapy-resistant tumors caused by COVID-19 mRNA vaccines, there is no credible scientific evidence to support this assertion.
- The FDA has taken a stance against using ivermectin for COVID-19 treatment and even agreed to remove posts promoting its use on social media.
- A lawsuit was filed against the FDA by doctors Paul Marik, Mary Talley Bowden, and Robert Apter, who claim the FDA is hindering their right to practice medicine.
- Ivermectin should not be used as a primary cancer treatment without seeking the advice of healthcare providers, as it is currently experimental and lacks approved guidelines.
- Ivermectin's sensitivity varies across cancer cell lines, showing the most promising results in ovarian, breast, and brain cancers, while being least effective in osteosarcoma, gastric, and melanoma.
- When considering cancer therapies and treatments, it's essential to base decisions on the best available evidence, not misleading information.
- The debate over ivermectin's role in cancer treatment has garnered attention in the general news, entertainment, and even in crime-and-justice discussions.
- Health-and-wellness, finance, and business magazines have covered the ongoing legal battles between doctors and the FDA regarding ivermectin and its potential uses.
- The use of ivermectin in cancer treatment remains a contentious issue, but education-and-self-development resources like Robert F. Kennedy Jr's tweets and Dr. Mary Talley Bowden's comments continue to serve as voices for those advocating for its use.
- As the investigation into the potential benefits of ivermectin for cancer treatment continues, it's crucial to maintain a balanced approach that considers financial investments in new therapies and treatments, while also focusing on food-and-drink intake and overall lifestyle choices for holistic health improvement.
